Suchergebnisse - "Rejeski, Kai"

PubPharm (64)

41

Oligoclonal T-cell expansion in a patient with bone marrow failure after CD19 CAR-T therapy for Richter-transformed DLBCL

enthalten in: Blood | 2022

von Rejeski, K. | Wu, Z. | Blumenberg, V. | +11

42

Chimeric Antigen Receptor T-cell Therapy : Imaging Response Criteria and Relation to Progression-free and Overall Survival

enthalten in: HemaSphere | 2022

von Winkelmann, M. | Rejeski, K. | Blumenberg, V. | +10

43

T-cell exhaustion induced by continuous bispecific molecule exposure is ameliorated by treatment-free intervals

enthalten in: Blood | 2022

von Philipp, N. | Kazerani, M. | Nicholls, A. | +22

CommentIn: Blood. 2022 Sep 8;140(10):1056-1058. - PMID 36074532

44

Increased visceral fat distribution and body composition impact cytokine release syndrome onset and severity after CD19 chimeric antigen receptor T-cell therapy in advanced B-cell malignancies

enthalten in: Haematologica | 2022

von Dos Santos, D. | Rejeski, K. | Winkelmann, M. | +10

45

Safety and feasibility of stem cell boost as a salvage therapy for severe hematotoxicity after CD19 CAR T-cell therapy

enthalten in: Blood advances | 2022

von Rejeski, K. | Burchert, A. | Iacoboni, G. | +14

46

Real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma

enthalten in: Blood advances | 2022

von Iacoboni, G. | Rejeski, K. | Villacampa, G. | +19

47

The CAR-HEMATOTOX risk-stratifies patients for severe infections and disease progression after CD19 CAR-T in R/R LBCL

enthalten in: Journal for immunotherapy of cancer | 2022

von Rejeski, K. | Perez, A. | Iacoboni, G. | +17

48

Neurofilament light chain serum levels correlate with the severity of neurotoxicity after CAR T-cell treatment

enthalten in: Blood advances | 2022

von Schoeberl, F. | Tiedt, S. | Schmitt, A. | +12

49

Toxicities and Response Rates of Secondary CNS Lymphoma After Adoptive Immunotherapy With CD19-Directed Chimeric Antigen Receptor T Cells

enthalten in: Neurology | 2022

von Karschnia, P. | Rejeski, K. | Winkelmann, M. | +10

50

The value of stereotactic biopsy of primary and recurrent brain metastases in the era of precision medicine

enthalten in: Frontiers in oncology | 2022

von Katzendobler, S. | Do, A. | Weller, J. | +10